Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Dalziel SM"'
Autor:
Long DD; Theravance Biopharma US, Inc., 901 Gateway Blvd., South San Francisco, California 94080, United States., Armstrong SR; Theravance Biopharma US, Inc., 901 Gateway Blvd., South San Francisco, California 94080, United States., Beattie DT; Theravance Biopharma US, Inc., 901 Gateway Blvd., South San Francisco, California 94080, United States., Campbell CB; Theravance Biopharma US, Inc., 901 Gateway Blvd., South San Francisco, California 94080, United States., Church TJ; Theravance Biopharma US, Inc., 901 Gateway Blvd., South San Francisco, California 94080, United States., Colson PJ; Theravance Biopharma US, Inc., 901 Gateway Blvd., South San Francisco, California 94080, United States., Dalziel SM; Theravance Biopharma US, Inc., 901 Gateway Blvd., South San Francisco, California 94080, United States., Jacobsen JR; Theravance Biopharma US, Inc., 901 Gateway Blvd., South San Francisco, California 94080, United States., Jiang L; Theravance Biopharma US, Inc., 901 Gateway Blvd., South San Francisco, California 94080, United States., Obedencio GP; Theravance Biopharma US, Inc., 901 Gateway Blvd., South San Francisco, California 94080, United States., Rapta M; Theravance Biopharma US, Inc., 901 Gateway Blvd., South San Francisco, California 94080, United States., Saito D; Theravance Biopharma US, Inc., 901 Gateway Blvd., South San Francisco, California 94080, United States., Stergiades I; Theravance Biopharma US, Inc., 901 Gateway Blvd., South San Francisco, California 94080, United States., Tsuruda PR; Theravance Biopharma US, Inc., 901 Gateway Blvd., South San Francisco, California 94080, United States., Van Dyke PM; Theravance Biopharma US, Inc., 901 Gateway Blvd., South San Francisco, California 94080, United States., Vickery RG; Theravance Biopharma US, Inc., 901 Gateway Blvd., South San Francisco, California 94080, United States.
Publikováno v:
ACS medicinal chemistry letters [ACS Med Chem Lett] 2019 Nov 26; Vol. 10 (12), pp. 1641-1647. Date of Electronic Publication: 2019 Nov 26 (Print Publication: 2019).
Autor:
Menning MM; Technical Operations, Tobira Therapeutics, Inc. , South San Francisco, California 94080, United States., Dalziel SM
Publikováno v:
Molecular pharmaceutics [Mol Pharm] 2013 Nov 04; Vol. 10 (11), pp. 4005-15. Date of Electronic Publication: 2013 Sep 04.